CAROLYN ELLIS: Open Payments
NPI 1841555398 · BANGOR, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$879 in 35 payments from 10 companies in 2025. Trend: 2023 $1,816 · 2024 $858 · 2025 $879
Food & beverage: $789Education: $90
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 8 | $317 |
| ABBVIE INC. | 14 | $186 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $90 |
| Amgen Inc. | 4 | $85 |
| GENZYME CORPORATION | 2 | $72 |
| UCB, Inc. | 2 | $48 |
| Lilly USA, LLC | 1 | $27 |
| Incyte Corporation | 1 | $27 |
| Janssen Biotech, Inc. | 1 | $23 |
| Organon LLC | 1 | $4 |
Products named: NEMLUVIO, SKYRIZI, OTEZLA, DUPIXENT, Bimzelx, EBGLYSS, OPZELURA, RINVOQ.
Industry payments across ME — which companies pay providers there.
